<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3731</id>
  <title>T3D3678</title>
  <common-name>Cytochalasin D</common-name>
  <description>Cytochalasins are mycotoxins that have the ability to bind to actin filaments and block polymerization and the elongation of actin. As a result, they can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. Cytochalasins also have the ability to permeate cell membranes, prevent cellular translocation, cause cells to enucleate, and affect other aspects of biological processes unrelated to actin polymerization. Cytochalasin D is has been isolated from the fungi Metarrhizium anisopliae and Zygosporium masonii. It also possesses antibiotic and antitumor activity. (A2910, A2911, L1913, L1916, A2912)</description>
  <cas>22144-77-0</cas>
  <pubchem-id>6433799</pubchem-id>
  <chemical-formula>C30H37NO6</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>255°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. Cytochalasin D also inhibits protein synthesis. (A2910, A2911, L1913)</mechanism-of-toxicity>
  <metabolism nil="true"/>
  <toxicity>LD50: 18.5 mg/kg (Subcutaneous, Mouse) (A2912)</toxicity>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Cytochalasin D is has been isolated from the fungi Metarrhizium anisopliae and Zygosporium masonii. (A2912)</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Major biological effects of cytochalasins include inhibition of the division of cytoplasm, reversible inhibition of cell movement, induction of nuclear extrusion, inhibition of such processes as phagocytosis, platelet aggregation and clot retraction, glucose transport, thyroid secretion, and release of growth hormone. Some cytochalasins have been shown to have developmental effects. (L1916)</health-effects>
  <symptoms nil="true"/>
  <treatment>Consider activated charcoal after gastrointestinal absportion. Nitroprusside is recommended to reverse peripheral ischemia secondary to vasoconstriction and for the treatment of hypertension. Anticoagulant therapy with intravenous heparin is also recommended. (A704)</treatment>
  <created-at type="dateTime">2010-04-16T17:41:35Z</created-at>
  <updated-at type="dateTime">2026-03-31T20:45:27Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>http://en.wikipedia.org/wiki/Cytochalasin_D</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1C2C(CC3=CC=CC=C3)NC(=O)C22C(\C=C\CC(C)C(=O)C(C)(O)\C=C\C2OC(C)=O)C(O)C1=C</moldb-smiles>
  <moldb-formula>C30H37NO6</moldb-formula>
  <moldb-inchi>InChI=1S/C30H37NO6/c1-17-10-9-13-22-26(33)19(3)18(2)25-23(16-21-11-7-6-8-12-21)31-28(35)30(22,25)24(37-20(4)32)14-15-29(5,36)27(17)34/h6-9,11-15,17-18,22-26,33,36H,3,10,16H2,1-2,4-5H3,(H,31,35)/b13-9+,15-14+</moldb-inchi>
  <moldb-inchikey>SDZRWUKZFQQKKV-BBXOWAOSSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">507.6179</moldb-average-mass>
  <moldb-mono-mass type="decimal">507.262087921</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id>CHEMBL1975837</chembl-id>
  <chemspider-id>4938858</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002647</chemdb-id>
  <dsstox-id>DTXSID8037099</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00011653</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>112.93</moldb-polar-surface-area>
  <moldb-refractivity>141.5228</moldb-refractivity>
  <moldb-polarizability>54.535388722550806</moldb-polarizability>
  <moldb-rotatable-bond-count>4</moldb-rotatable-bond-count>
  <moldb-acceptor-count>5</moldb-acceptor-count>
  <moldb-donor-count>3</moldb-donor-count>
  <moldb-pka-strongest-acidic>12.848232228884065</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-0.3728268033187402</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>4</moldb-number-of-rings>
  <moldb-alogps-logp>2.89</moldb-alogps-logp>
  <moldb-alogps-logs>-4.94</moldb-alogps-logs>
  <moldb-alogps-solubility>5.80e-03 g/l</moldb-alogps-solubility>
</compound>
